Skip to main content Skip to navigation
BD Vacutainer® CPT™ Mononuclear Cell Preparation Tube - Sodium Citrate

BD Vacutainer® CPT™ Mononuclear Cell Preparation Tube - Sodium Citrate

(RUO)
Product Details
Down Arrow Up Arrow


Description

BD Vacutainer® CPT™ is a fully-closed system for separation of mononuclear cells from whole blood, where cell separation is carried out in the primary blood collection tube. This decreases the complexity of steps for mononuclear cell separation, thereby minimizing variability from sample processing.

CPT™ is an evacuated, sterile blood collection tube containing buffered sodium citrate or sodium heparin anticoagulant, liquid density medium and an inert gel barrier. It is intended for the collection of whole blood and the subsequent separation of mononuclear blood cells for the purposes of in vitro diagnostic examination.

Whole blood is drawn directly into the CPT™ using standard phlebotomy techniques and processed in the same tube. During centrifugation, the gel forms a physical barrier between the mononuclear cells in plasma and the erythrocytes and granulocytes. The separated, concentrated suspension of mononuclear cells in plasma can then be transported in the primary blood collection tube.


Tube MaterialGlass
Tube Size13x100 mm
Draw Volume4 mL
Closure TypeConventional Stopper
Closure ColorBlue / Black
LabelMylar (transparent)
AnticoagulantSodium Citrate
AdditiveFicoll™ Hypaque™ Solution
SterilizationAutoclave , 10-6 SAL , ISO17665-1


Preparation And Storage

Store BD Vacutainer® CPT™ Tubes upright at room temperature (18-25° C). Protect tubes from direct light. Shelf life at 18-25ºC is one year from the date of manufacture.

Please refer to Support Documents for Quality Certificates

Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described

Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims.  Comparisons are not made against non-BD technologies, unless otherwise noted.